128 related articles for article (PubMed ID: 24989136)
1. Stable expression and characterization of monomeric and dimeric recombinant hybrid-IgG/IgA immunoglobulins specific for Shiga toxin.
Iwata K; Kurohane K; Nakanishi K; Miyake M; Imai Y
Biol Pharm Bull; 2014; 37(9):1510-5. PubMed ID: 24989136
[TBL] [Abstract][Full Text] [Related]
2. Shiga toxin-induced apoptosis is more efficiently inhibited by dimeric recombinant hybrid-IgG/IgA immunoglobulins than by the parental IgG monoclonal antibodies.
Kurohane K; Nagano K; Nakanishi K; Iwata K; Miyake M; Imai Y
Virulence; 2014; 5(8):819-24. PubMed ID: 25469594
[TBL] [Abstract][Full Text] [Related]
3. Characterization of monoclonal immunoglobulin a and g against shiga toxin binding subunits produced by intranasal immunization.
Tanikawa T; Ishikawa T; Maekawa T; Kuronane K; Imai Y
Scand J Immunol; 2008 Oct; 68(4):414-22. PubMed ID: 18782271
[TBL] [Abstract][Full Text] [Related]
4. Establishment of recombinant hybrid-IgG/IgA immunoglobulin specific for Shiga toxin.
Tobisawa Y; Maruyama T; Tanikawa T; Nakanishi K; Kurohane K; Imai Y
Scand J Immunol; 2011 Dec; 74(6):574-84. PubMed ID: 21883352
[TBL] [Abstract][Full Text] [Related]
5. Production of hybrid-IgG/IgA plantibodies with neutralizing activity against Shiga toxin 1.
Nakanishi K; Narimatsu S; Ichikawa S; Tobisawa Y; Kurohane K; Niwa Y; Kobayashi H; Imai Y
PLoS One; 2013; 8(11):e80712. PubMed ID: 24312238
[TBL] [Abstract][Full Text] [Related]
6. Prevention of Shiga toxin 1-caused colon injury by plant-derived recombinant IgA.
Nakanishi K; Takase T; Ohira Y; Ida R; Mogi N; Kikuchi Y; Matsuda M; Kurohane K; Akimoto Y; Hayakawa J; Kawakami H; Niwa Y; Kobayashi H; Umemoto E; Imai Y
Sci Rep; 2022 Oct; 12(1):17999. PubMed ID: 36289440
[TBL] [Abstract][Full Text] [Related]
7. Lettuce-derived secretory IgA specifically neutralizes the Shiga toxin 1 activity.
Nakanishi K; Matsuda M; Ida R; Hosokawa N; Kurohane K; Niwa Y; Kobayashi H; Imai Y
Planta; 2019 Oct; 250(4):1255-1264. PubMed ID: 31222495
[TBL] [Abstract][Full Text] [Related]
8. Production of IgA monoclonal antibody against Shiga toxin binding subunits employing nasal-associated lymphoid tissue.
Imai Y; Ishikawa T; Tanikawa T; Nakagami H; Maekawa T; Kurohane K
J Immunol Methods; 2005 Jul; 302(1-2):125-35. PubMed ID: 15992815
[TBL] [Abstract][Full Text] [Related]
9. Simplifying the synthesis of SIgA: combination of dIgA and rhSC using affinity chromatography.
Moldt B; Saye-Francisco K; Schultz N; Burton DR; Hessell AJ
Methods; 2014 Jan; 65(1):127-32. PubMed ID: 23811333
[TBL] [Abstract][Full Text] [Related]
10. Production of secretory immunoglobulin A against Shiga toxin-binding subunits in mice by mucosal immunization.
Imai Y; Nagai R; Ono Y; Ishikawa T; Nakagami H; Tanikawa T; Kurohane K
Infect Immun; 2004 Feb; 72(2):889-95. PubMed ID: 14742533
[TBL] [Abstract][Full Text] [Related]
11. Recombinant dimeric IgA antibodies against the epidermal growth factor receptor mediate effective tumor cell killing.
Lohse S; Derer S; Beyer T; Klausz K; Peipp M; Leusen JH; van de Winkel JG; Dechant M; Valerius T
J Immunol; 2011 Mar; 186(6):3770-8. PubMed ID: 21317397
[TBL] [Abstract][Full Text] [Related]
12. Interference of coronavirus infection by expression of immunoglobulin G (IgG) or IgA virus-neutralizing antibodies.
Castilla J; Sola I; Enjuanes L
J Virol; 1997 Jul; 71(7):5251-8. PubMed ID: 9188593
[TBL] [Abstract][Full Text] [Related]
13. [In vitro Antiviral Activity of Recombinant Antibodies of IgG and IgA Isotypes to Hemagglutinin of the Influenza A Virus].
Argentova VV; Aliev TK; Zarubaev VV; Klotchenko SA; Shtro AA; Sergeeva MV; Toporova VA; Dolgikh DA; Sveshnikov PG; Vasin VA; Kirpichnikov MP
Mol Biol (Mosk); 2017; 51(6):927-937. PubMed ID: 29271957
[TBL] [Abstract][Full Text] [Related]
14. Recombinant immunoglobulin A specific for influenza A virus hemagglutinin: production, functional analysis, and formation of secretory immunoglobulin A.
Shoji K; Takahashi T; Kurohane K; Iwata K; Matsuoka T; Tsuruta S; Sugino T; Miyake M; Suzuki T; Imai Y
Viral Immunol; 2015 Apr; 28(3):170-8. PubMed ID: 25658886
[TBL] [Abstract][Full Text] [Related]
15. Plant-derived secretory component forms secretory IgA with shiga toxin 1-specific dimeric IgA produced by mouse cells and whole plants.
Nakanishi K; Morikane S; Hosokawa N; Kajihara Y; Kurohane K; Niwa Y; Kobayashi H; Imai Y
Plant Cell Rep; 2019 Feb; 38(2):161-172. PubMed ID: 30506369
[TBL] [Abstract][Full Text] [Related]
16. Interference of coronavirus infection by expression of IgG or IgA virus neutralizing antibodies.
Sola I; Castilla J; Enjuanes L
Adv Exp Med Biol; 1998; 440():665-74. PubMed ID: 9782343
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of antigen specificities in the monomeric and dimeric fractions of intravenous immunoglobulin.
Miescher SM; Schaub A; Ghielmetti M; Baumann M; Vogel M; Bolli R; Stadler B
Ann N Y Acad Sci; 2005 Jun; 1051():582-90. PubMed ID: 16126998
[TBL] [Abstract][Full Text] [Related]
18. Shiga-like toxin binds with high avidity to multivalent O-linked blood group P1 determinants on mucin-type fusion proteins.
Maria Cherian R; Gaunitz S; Nilsson A; Liu J; Karlsson NG; Holgersson J
Glycobiology; 2014 Jan; 24(1):26-38. PubMed ID: 24082034
[TBL] [Abstract][Full Text] [Related]
19. Recombinant expression of polymeric IgA: incorporation of J chain and secretory component of human origin.
Johansen FE; Natvig Norderhaug I; Røe M; Sandlie I; Brandtzaeg P
Eur J Immunol; 1999 May; 29(5):1701-8. PubMed ID: 10359125
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal IgA class-switch variants against bacterial surface antigens: molecular forms and transport into murine respiratory secretions.
Steinmetz I; Albrecht F; Häussler S; Brenneke B
Eur J Immunol; 1994 Nov; 24(11):2855-62. PubMed ID: 7957576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
